newsfilter
← Latest News
GlobeNewswire·

Impel NeuroPharma to Ring Nasdaq Closing Bell on Monday, April 25

SEATTLE, April 21, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the ce